Matthew Heeney

Matthew Heeney, MD

Director, Clinical Hematology; Director, Sickle Cell Program

Assistant Professor of Pediatrics, Harvard Medical School

  • Contact: 617-355-7700

  • Fax: 617-730-0641

Medical Services

Specialties

  • Sickle Cell Disease
  • Iron Deficiency
  • Hemoglobinopathies
  • Hematology Oncology
  • Sideroblastic Anemia

Departments

  • Hematology / Oncology
  • Medicine

Languages

  • English

Programs

  • Hematology / Oncology
  • Hematology / Oncology
  • Rare Anemias and Iron Disorders Program
To schedule an appointment: Call 617-355-7700 or Request an Appointment

Experience and Education

Education

Undergraduate

Trinity College, University of Toronto, 1992

Toronto, Canada

Medical School

University of Calgary, 1995

Calgary, Canada

Fellowship, Pediatric Hematology/Oncology

Duke University Medical Center, 1999-2002

Durham, NC

Residency

Montreal Children's Hospital, McGill University, 1995-1999

Montreal, Canada

Certifications

  • Pediatrics, Pediatric Hematology/Oncology

Research

Dr. Heeney conducts clinical research focused on sickle cell disorders and their treatment. He has been the Children's Hospital Boston Principal Investigator (PI) for the Boston Comprehensive Sickle Cell Center (CSCC)and the Boston Sickle Cell Disease Research Network (SCDCRN). He is the CHB PI and for the multicenter SWiTCH and TWiTCH trials which are exploring the use of Hydroxyurea as an alternative to chronic transfusion for stroke prevention. Dr. Heeney also conducts translational research in inherited disorders of iron homeostasis in humans. In particular he is interested in investigating the genetic basis inherited disorders of iron deficiency, sideroblastic anemia and iron overload. Goals of Dr. Heeney's work include: to improve the understanding of the pathophysiology and treatment of sickle cell anemia through multicenter clinical trials and to elucidate the genetic basis of iron homeostasis and its role in human disease.

Professional History

Matthew Heeney, MD is Board Certified in Pediatrics and Pediatric Hematology/Oncology. He is the Associate Chief for Hematology in the Division of Hematology/Oncology and the Director of the Sickle Cell Program in the Dana-Farber Boston Children’s Cancer and Blood Disorders Center (DFBCCBD). Dr. Heeney’s research Interests are focused on sickle cell disease and congenital disorders of iron metabolism. The goals of Dr. Heeney's research work include: to improve the understanding of the pathophysiology and treatment of sickle cell anemia through clinical investigation and to elucidate the genetic basis of iron homeostasis and its role in human disease.
Dr. Heeney has been the Boston Children's Hospital Site Investigator for several clinical trial consortia including the former Sickle Cell Disease Research Network (SCDCRN), and Comprehensive Sickle Cell Center (CSCC). He is also the Site Investigator for the multicenter SWiTCH and TWiTCH trials which are exploring the use of Hydroxyurea as an alternative to chronic transfusion for stroke prevention in sickle cell disease. He is also involved in early phase trials of prasugrel and regadenoson in sickle cell disease. Dr. Heeney also conducts translational research in inherited disorders of iron homeostasis in humans. In particular he is interested in investigating the genetic basis inherited disorders of iron deficiency, sideroblastic anemia and iron overload.
Dr. Heeney is an Assistant Professor of Pediatrics at Harvard Medical School and is committed to medical education as the Co-Director of the Hematology course for 2nd year HMS students. He is a frequent lecturer on hematology topics in HMS sponsored continuing medical education and BCH training programs.. Dr. Heeney received his MD at the University of Calgary, Alberta, completed his pediatrics residency at Montreal Children's Hospital, McGill University, and a pediatric hematology/oncology fellowship at Duke University.

To schedule an appointment: Call 617-355-7700 or Request an Appointment

Locations

View Location:

The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944

Close